Jordan Farley, DO
Pain Medicine · Creve Coeur, MONPI 1669979340
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (45.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 61.6% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $3,000 and has fallen 89.5% since, to $314 in 2025.
Across 53 payments — averaging $124.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Abbott$2K
- Boston Scientific$675
- SPR Therapeutics, Inc$130
- Piramal Critical Care$126
- AbbVie$28
- plus $32 from 2 others
What the payments were for
- Grants$3,00046%
- Travel & lodging$1,45422%
- Food & beverage$2,12532%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 20 | $4,049 |
| Abbott | 23 | $1,537 |
| Boston Scientific | 5 | $675 |
| SPR Therapeutics, Inc | 1 | $130 |
| Piramal Critical Care | 1 | $126 |
| AbbVie | 1 | $28 |
| Nalu Medical, Inc. | 1 | $18 |
| Globus Medical | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$3,000
- PROCLAIM$861
- GABLOFEN$506
- INTELLIS ADAPTIVESTIM$444
- SPRINT PNS System$130
- ETERNA$104
How this compares
$6,578 in reported general payments places this provider in the 75th percentile of 124 pain medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 101 | $827 |
| Methocarbamol | 61 | $680 |
| Cyclobenzaprine Hcl | 18 | $254 |
| Duloxetine Hcl | 11 | $184 |
| Baclofen | 11 | $164 |
| Meloxicam | 54 | $144 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $133 |
| Amitriptyline Hcl | 20 | $114 |
| Tizanidine Hcl | 15 | $104 |
| Methylprednisolone | 17 | $73 |
| Tramadol Hcl | 11 | $35 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Creve Coeur
- Christopher ReisCape Girardeau$113K
- Anne ChristopherChesterfield$104K
- Tyler ConcannonKansas City$64K
- Vinicius Tieppo FrancioSaint Louis$35K
- Luvell GlantonHannibal$33K
- Jooyoung MaengSaint Louis$25K
- Travis FoxxLiberty$23K
- Nabil AhmadSaint Louis$21K
- Chad SheltonSaint Peters$18K
- Katharine GurbaSaint Louis$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.